ADCI Stock Overview
The Arab Drug Company produces and sells pharmaceutical products.
The Arab Drug Company Competitors
Price History & Performance
|Historical stock prices|
|Current Share Price||ج.م54.80|
|52 Week High||ج.م58.00|
|52 Week Low||ج.م41.00|
|1 Month Change||3.45%|
|3 Month Change||19.55%|
|1 Year Change||7.87%|
|3 Year Change||27.59%|
|5 Year Change||81.52%|
|Change since IPO||340.36%|
Recent News & Updates
|ADCI||EG Pharmaceuticals||EG Market|
Return vs Industry: ADCI underperformed the EG Pharmaceuticals industry which returned 19.7% over the past year.
Return vs Market: ADCI underperformed the EG Market which returned 19.3% over the past year.
|ADCI Average Weekly Movement||3.2%|
|Pharmaceuticals Industry Average Movement||4.7%|
|Market Average Movement||5.7%|
|10% most volatile stocks in EG Market||9.0%|
|10% least volatile stocks in EG Market||3.6%|
Stable Share Price: ADCI is less volatile than 75% of EG stocks over the past 3 months, typically moving +/- 3% a week.
Volatility Over Time: ADCI's weekly volatility (3%) has been stable over the past year.
About the Company
|1963||1,148||R. Samah Abdel-Yassiz||https://www.adcopharma.com|
The Arab Drug Company produces and sells pharmaceutical products. It offers ampoules, tablets, syrups, solutions, capsules, aerosol sprays, metered dose inhalers, granulated powder for suspension, creams, ointments, and suppositories. The company was incorporated in 1963 and is based in Cairo, Egypt.
The Arab Drug Company Fundamentals Summary
|ADCI fundamental statistics|
Is ADCI overvalued?See Fair Value and valuation analysis
Earnings & Revenue
|ADCI income statement (TTM)|
|Cost of Revenue||ج.م315.34m|
Last Reported Earnings
Dec 31, 2021
Next Earnings Date
|Earnings per share (EPS)||15.53|
|Net Profit Margin||17.70%|
How did ADCI perform over the long term?See historical performance and comparison